Lisa Taliadoros

Jones Day (Sydney)
Lawyer (Partner)

Head of the Intellectual Property Practice in Australia, Lisa Taliadoros has nearly 20 years of experience in high-value IP disputes, including in relation to patents, copyrights, and trademarks. A focus of Lisa’s practice is complex, multijurisdictional patent litigation in the Federal Court of Australia. She has acted across a range of industries, including pharmaceuticals, life sciences, biotechnology, mining, and building and construction. Lisa has acted in the High Court of Australia in two recent landmark decisions concerning the scope of patent protection for Myriad’s BRA1 (breast cancer) patents and Sanofi’s leflunomide patent for the treatment of skin disorders and arthritic conditions. In addition, she has acted in the Federal Court of Australia for other large multinational pharmaceutical companies in matters relating to patents for new compounds, biologics, biosimilars, drug formulations, drug delivery devices, dental technology, and methods of treatment. She also has acted in matters concerning patents relating to mining tools and technologies (including deep water drilling apparatus) and building systems. Lisa is a member of the Intellectual Property Law Subcommittee of the Law Council of Victoria. Prior to obtaining her law degree, Lisa was a scientist at two of Australia’s preeminent research organizations, the CSIRO and the Centenary Institute of Cell Biology and Cancer Medicine. Her research projects involved the development of vaccines for avian infectious bronchitis virus and investigating the role of lymphotoxin alpha in the pathogenesis of autoimmune disorders. Lisa serves as Jones Day’s diversity partner for Australia.

Linked author

Jones Day (Sydney)

Articles

50 Bulletin

Send a message